GREAT FOR BUSINESS
The 2018 Farm Bill, signed into law in December 2018, legalizes the farming and processing of hemp, and the distribution of products with CBD as an ingredient in all states.
Hemp is no longer a controlled substance
The removal of hemp from the Federal list of controlled substances also means that businesses in the hemp industry now have access to banking and financial services, credit cards and payment processors. Restrictions on capital investments have been lifted and products can be traded across state boarders. Insurance is available for growers and hemp can be traded on the futures market. Furthermore, research into hemp and its benefits is more widely allowed.
CBD is a non-psychoactive compound
However, the FDA retains the authority to regulate products containing CBD and stated they will treat them as they do any other FDA regulated products.
Changes in the legal status of hemp and regulation are good news for investors in businesses involved with the hemp industry. The Hemp Industry Daily projects that the hemp-derived CBD retail market will reach up to $3.1 billion by 2022.
Nerovana is a privately held California corporation. To inquire about investing, contact us at email@example.com
Chief Executive Officer, Co-Founder / Director
As the CEO of Nerovana, Andy is a corporate venture development executive with an extensive background in marketing, brand creation, international trade financing and logistics and manufacturing outsourcing.
Chief Strategy Officer, Co-Founder / Director
William brings years of corporate management and financial experience to the team. He helps companies arrange financing and prepare for successful exits, including IPOs in the U.S. and Canada and sets strategies for growth and partnerships.
Chief Operating Officer / Director
Brian has experience in the cannabis industry as managing partner for Premier LA Pre-ICO Dispensary and Brand Managing Partner for Canna Genetics. He is the 3rd generation family farm owner and operator of hemp farms in Colorado, Washington, Oregon and Southern California.
Doug Thomas, Ph.D.
Chief Scientist / Executive Vice President
Doug has 20+ years experience in the biopharmaceutical and topical drug industries in core research, formulation development and manufacturing. He is responsible for Nerovana's research and commercialization processes.
Dr. Szu Yuan Wu MD. Ph.D.
Radiation & Cancer Specialist
Dr. March Hoang Ph.D.
Dr. Steven ZhangChinese
Herbalist & Acupuncturist
Dr. Howard Hsu
Chinese Herbalist & Acupuncturist
Dr. Richard Lee
Botanical Extraction Specialist
Wellness Product Development
Kenneth Spiker Jr.
Political Lobbyist & Compliance